Cocrystal Pharma, Inc.
COCP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20,551 | $16,600 | $15,879 | $59,975 |
| - Cash | $9,860 | $26,353 | $37,144 | $58,705 |
| + Debt | $1,806 | $1,853 | $297 | $534 |
| Enterprise Value | $12,497 | -$7,900 | -$20,968 | $1,804 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$12,537 | -$15,169 | -$12,392 | -$8,794 |
| % Margin | – | – | – | – |
| EBITDA | -$17,752 | -$20,970 | -$17,952 | -$14,031 |
| % Margin | – | – | – | – |
| Net Income | -$17,504 | -$17,984 | -$38,837 | -$14,185 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.72 | -0.002 | -4.77 | -1.85 |
| % Growth | -90,426.3% | 100% | -157.8% | – |
| Operating Cash Flow | -$16,485 | -$14,666 | -$21,435 | -$12,719 |
| Capital Expenditures | -$8 | -$118 | -$74 | -$52 |
| Free Cash Flow | -$16,493 | -$14,784 | -$21,509 | -$12,771 |